CDER

FDA
Favicon Fierce Pharma

George Tidmarsh exits as LinkedIn post sparks lawsuit, probe

A recent LinkedIn post has landed the now-departed CDER chief at the center of an Aurinia lawsuit and an internal probe.
Fraiser Kansteiner Nov 3, 2025 11:13am
yellow road to bright light

FDA proposes new approval pathway for rare diseases

Sep 3, 2025 1:20pm
target reach ladder climb meet win beat competition
Favicon Fierce Pharma

FDA taps new CDER chief as acting CBER head after Prasad exit

Jul 30, 2025 1:10pm
FDA
Favicon Fierce Pharma

FDA taps George Tidmarsh to lead CDER

Jul 21, 2025 10:53am
FDA
Favicon Fierce Pharma

FDA's acting CDER head heads for the exit: report

Jun 23, 2025 1:48pm
Delayed on hold

Vanda sues FDA over months-long hearing delay

Apr 23, 2025 10:33am